NexusTrade Loading NexusTrade… Taking too long? Reload this page

About Quest Diagnostics Inc. (DGX)

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also provides diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, emerging retail healthcare providers, pharmaceutical companies and insurers, commercial clinical laboratories, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. In addition, the company offers risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.

Ticker
DGX
Exchange
XNYS
Sector
Healthcare
Industry
Diagnostics & Research

Company profile updated October 15, 2026.

Stored market snapshot

As of October 12, 2026. Daily closing data may differ from the live quote shown in the dashboard.

Stored daily close (USD)
$232.63
Company market capitalization (USD)
$25,676,154,736.8
Price / earnings (TTM)
24.18×

Research DGX

Compare the company’s price history and fundamentals in the dashboard. Explore disclosed trading and ownership activity in these research collections: